Home » Topics » Science » Drug design, drug delivery and technologies

Drug design, drug delivery and technologies
RSS

New HIV-based gene delivery system pioneered at Oxford BioMedica

Jan. 22, 1998

Genetronics to begin phase II head and neck cancer trial in Canada

Jan. 22, 1998

T Cell Sciences and Walter Reed collaborate on inhibition of liposome-induced complement activation

Jan. 22, 1998

Repligen and Glaxo extend Glyceptor collaboration

Jan. 22, 1998

Dynavax and Vical crosslicense DNA immunization technology

Jan. 21, 1998

Ribozyme, Parke-Davis intend to collaborate

Jan. 20, 1998

Pharmacopeia achieves milestone in collaboration with Daiichi

Jan. 20, 1998

Lilly acquires rights to Sibia's drug discovery technology

Jan. 20, 1998

Lexicon and ZymoGenetics sign functional genomics agreement

Jan. 20, 1998

Inhale and Lilly to codevelop pulmonary delivery formulation

Jan. 20, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 17, 2026.
Celia trial: data strong, analysts skeptical
BioWorld
Tuesday brought what was arguably the most anticipated presentation of the 2026 Alzheimer’s Association International Conference when Catherine Mummery, head of...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026
Dual FAAH/MAGL inhibition targets Alzheimer’s disease hyperexcitability
BioWorld Science
Reduced endocannabinoid signaling has been linked to neuronal hyperexcitability in Alzheimer’s disease (AD), suggesting that dual inhibition of fatty acid amide...
ALN-5288 lowers tau levels in preclinical models
BioWorld Science
Pathological tau accumulation is a key driver of neurodegeneration in Alzheimer’s disease (AD) and other tauopathies such as progressive supranuclear palsy....